arrow
M

Marta Cobo Marcos

Hospital Universitario Puerta de Hierro Majadahonda
H指数:30
被引数:4,364

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lower limb compression in acute heart failure and predominant tissue congestion: rationale and design of the COMPRESSION-HF trial

急性心力衰竭和主要组织淤血中的下肢加压:COMPRESSION-HF试验的原理与设计

2026-08-120
OAAI
Chronic obstructive pulmonary disease and CA125 levels in ambulatory chronic heart failure: The COPA-HF study

慢性阻塞性肺疾病与CA125水平在门诊慢性心力衰竭中的应用:COPA-HF研究

2026-07-010
PRE
Impact of dapagliflozin on key pathophysiological pathways underlying chronic heart failure progression: the DAPA-MODA biomarker study

达格列净对慢性心力衰竭进展下关键病理生理通路的影响:DAPA-MODA生物标志物研究

2026-05-010
OA
Redefining Cardiometabolic Disease: Expert Consensus on the CardioVascular–Kidney–Liver–Metabolic (CVKLM) Multiorgan Staging

重新定义心血管代谢疾病:心血管-肾脏-肝脏-代谢(CVKLM)多器官分期的专家共识

2026-01-010
OA
Lipid control in a cohort of patients with cardiorenal disease (LIPID-REN): a subanalysis of the CARDIOREN registry

脂质控制在心肾疾病患者队列中的研究(LIPID-REN):CARDIOREN注册研究的亚组分析

2026-01-010
OAAI
Urinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document

心力衰竭中的尿路标志物——类型、时机和阈值。欧洲心力衰竭杂志专家共识文件

2025-11-030
OAAI
The chloride paradigm shift in heart failure: From neglected ion to keystone of precision diuretic therapy

氯离子在心力衰竭中的范式转变:从被忽视的离子到精准利尿疗法的基石

2025-10-290
PRE
Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

达格列净对接受经导管主动脉瓣植入术的主动脉瓣狭窄患者生活质量的影响

JACC
IF0
2025-10-060
PRE
Baseline characteristics and decision-making in the management of incident and recurrent hyperkalaemia in Spain: Interim results from the prospective TRACK study

基线特征和西班牙地区新发及复发高钾血症管理中的决策制定:前瞻性TRACK研究的中期结果

2025-10-010
OA
Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study

血清生长分化因子15(GDF15)水平反映铁缺乏的心力衰竭患者中的缺血性病因:一项横断面研究

2025-09-210
OAAI
Sodium zirconium cyclosilicate, hyperkalaemia, and spironolactone optimization in heart failure with reduced ejection fraction: The REALIZE-K open-label run-in phase

锆硅酸钠、高钾血症及螺内酯优化在射血分数降低的心力衰竭中的应用:REALIZE-K开放标签的预实验阶段

2025-08-200
OAAI
The role of intra-abdominal pressure and point of care ultrasound to guide decongestive therapies in acute heart failure

腹腔内压力和床旁超声在指导急性心力衰竭患者去充血治疗中的作用

2025-07-300
OAAI
Heart Failure in Advanced Chronic Kidney Disease

晚期慢性肾病中的心力衰竭

2025-07-280
OA
Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factors

慢性与急性心力衰竭情景下的低氯血症:患病率与危险因素

2025-06-110
PRE
Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

finerenone在心力衰竭患者中的临床实用性和安全性: 精细注册的原理和设计

2025-02-010
OAAI
Different impact of chronic kidney disease in older patients with heart failure according to frailty

慢性肾脏病对老年心力衰竭患者衰弱程度的不同影响

2025-02-010
PRE
Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert
2024-12-010
PRE
Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries
2024-11-290
OAAI